GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment

Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Sudeep Pharma Ltd
Sudeep Pharma Board Meeting to Approve Q2/H1 FY27 Financial Results
RESULTS ● No Immediate Change LOW RISK
📅 Filed on BSE: 21 Oct 2026, 11:30 AM IST  ·  BSE ID: 1158f79a-015e-4765-8322-320e44d6345e
View Original BSE Filing (PDF)
💡
In Simple Terms
Sudeep Pharma will announce its financial results for the quarter and half year ending September 30, 2026, on October 28, 2026.
🤖 AI Summary
  • Sudeep Pharma's Board of Directors will meet on October 28, 2026, to approve Q2/H1 FY27 results.
  • The meeting will consider Unaudited Standalone and Consolidated Financial Results for September 30, 2026.
  • The trading window for company insiders closed on October 1, 2026, due to this upcoming event.
  • The trading window closure extends until October 30, 2026, post-declaration of financial results.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders based on this intimation of a Board Meeting.
👤
Who Is Affected
This announcement affects all shareholders by providing a timeline for the release of the company's Q2 and H1 FY27 financial performance data.
🔍
Management Signal
The scheduling of the Board Meeting indicates routine adherence to regulatory timelines for financial reporting.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Board Meeting outcome — review Unaudited Financial Results for Q2/H1 FY27.
Q2 FY27 revenue figures — assess performance against previous quarters.
Q2 FY27 net profit — compare against Q1 FY27 profit of Rs. 4,058.69 Lakhs.
LOW RISK This is a standard procedural announcement for results disclosure, carrying minimal inherent risk.
💡 Investor Takeaway
Sudeep Pharma has scheduled its Board Meeting for October 28, 2026, to approve its Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026. The insider trading window is closed from October 1 to October 30, 2026.
📅 Company Track Record
Sudeep Pharma reported a consolidated net profit of Rs. 4,058.69 Lakhs for Q1 FY27 (quarter ended June 30, 2026), marking a 29.80% year-on-year increase. The company consistently files its quarterly financial results.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
When is Sudeep Pharma's Board Meeting scheduled?
Sudeep Pharma Ltd's Board Meeting is scheduled for Wednesday, October 28, 2026.
What will be considered at the Sudeep Pharma Board Meeting on October 28, 2026?
The Board Meeting on October 28, 2026, will consider, approve, and take on record the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026.
When is the trading window closed for Sudeep Pharma insiders?
The trading window for Sudeep Pharma insiders closed on Thursday, October 1, 2026, and will remain closed until Friday, October 30, 2026 (both days inclusive).
What financial period will the upcoming Sudeep Pharma results cover?
The upcoming results will cover the financial performance for the quarter and half year ended September 30, 2026.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.